Biological
CD7 CAR-T cells infusion
CD7 CAR-T cells infusion is a biological therapy with 3 clinical trials. Currently 2 active trials ongoing.
Total Trials
3
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Active Trials
2(67%)
Phase Distribution
Ph phase_1
2
67%
Phase Distribution
2
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Phase 1Safety & dosage
2(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Other(1)
Detailed Status
Active, not recruiting1
Recruiting1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
Phase 1
Trials by Phase
Phase 12 (100.0%)
Trials by Status
active_not_recruiting133%
recruiting133%
unknown133%
Recent Activity
2 active trials
Showing 3 of 3
active_not_recruiting
Multi-omics Profiling of Patients With Aplastic Anemia Before and After CD7-CAR-T Therapy
NCT07139600
recruitingphase_1
CD7 CAR T-Cell Therapy for r/r T-cell Lymphomas
NCT06925464
unknownphase_1
CD7 CAR-T Cells for Patients With R/R CD7+ NK/T Cell Lymphoma,T-lymphoblastic Lymphoma and Acute Lymphocytic Leukemia
NCT04004637
Clinical Trials (3)
Showing 3 of 3 trials
NCT07139600
Multi-omics Profiling of Patients With Aplastic Anemia Before and After CD7-CAR-T Therapy
NCT06925464Phase 1
CD7 CAR T-Cell Therapy for r/r T-cell Lymphomas
NCT04004637Phase 1
CD7 CAR-T Cells for Patients With R/R CD7+ NK/T Cell Lymphoma,T-lymphoblastic Lymphoma and Acute Lymphocytic Leukemia
All 3 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 3